Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NT5DC4 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | PYROXD2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | EZH2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | PLEKHH3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | DCTN1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | C11orf42 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | TRPC3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | ANKDD1B | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | GAGE12B | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | ZNF687 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |